05 Feb 2013 Posted in ABPI statement By Press Office
We have been actively involved in progressing this issue with all stakeholders. The AllTrials campaign is one of a number of initiatives addressing the transparency issue. Others include the EMA work streams, the Science and Technology Committee Inquiry and changes to the ABPI Code of Practice in 2012. The decision to sign up to the Alltrials campaign is one for individual companies to make.
ABPI Press Office
Tel: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441
Mobile: +44 (0) 7850 312064 or +44 (0) 7808 641811
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by Government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.